SCHEMBL7873398

SCHEMBL7873398

NC(=O)NCCC[C@H](N)C(=O)Nc1ccccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.64
ALOX12 P18054 2/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GAA P10253 2/20 0.47
POLB P06746 1/20 0.46
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
PKM P14618 1/20 0.45
S1PR1 P21453 1/20 0.44
S1PR3 Q99500 1/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 1/20 0.43
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC7 Q8WUI4 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC10 Q969S8 2/20 0.42
HDAC11 Q96DB2 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7873431 0.80 ANPEP (0.77) ANPEPALOX12HTTSMN1; SMN2GAA
SCHEMBL7418597 0.80 POLB (0.55) ANPEPALOX12HTTSMN1; SMN2GAA
SCHEMBL7873419 0.79 ANPEP (1.00) ANPEPHTT
SCHEMBL7868176 0.78 ANPEP (0.59) ANPEPALOX12HTTSMN1; SMN2GAA
Hydrochloric Acid SCHEMBL7382206 0.78 ANPEP (0.98) ANPEPHTT
SCHEMBL7873450 0.77 ANPEP (0.61) ANPEPALOX12SMN1; SMN2GAAPOLB
SCHEMBL26741146 0.76 ALDH1A1 (0.60) ANPEPALOX12HTTSMN1; SMN2GAA
SCHEMBL26741187 0.76 ALDH1A1 (0.60) ANPEPALOX12HTTSMN1; SMN2GAA
SCHEMBL7876499 0.76 ANPEP (0.52) ANPEPSMN1; SMN2GAAPOLBNPC1
SCHEMBL7879250 0.76 ANPEP (0.60) ANPEPALOX12HTTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6329400-B1 INHIBITION OR ANTAGONISM OF MATRIX METALLOPROTEASES, AND/OR TUMOR NECROSIS FACTOR-ALPHA; EXTRACELLULAR MATRIX DEGRADATION, INHIBITION OF SHEDDING OF CELL SURFACE PROTEIN ECTODOMAINS AND CD23 PROTEOLYSIS GLAXO WELLCOME INC. 2001-12-11 US disclosed